ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A novel metabolic-related gene signature for predicting clinical prognosis and immune microenvironment in head and neck squamous cell carcinoma

Cao, Yongxin; Dai, Zili; Xie, Guofeng; Liu, Guihong; Guo, Liyi*; Zhang, Jian*广州医学院; 南方医科大学; 6
Experimental Cell Research2023-7-15DOI: 10.1016/j.yexcr.2023.113628
12阅读
引用收藏
分享

摘要

Objectives: Metabolic reprogramming is not only an essential hallmark in the progression of head and neck squamous cell carcinoma (HNSCC), but also an important regulator of cancer cell adaptation to tumor microenvironment (TME). However, the potential mechanism of metabolic reprogramming in TME of HNSCC is still unknown. Methods: The head and neck squamous cell carcinoma with survival information were obtained the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. The metabolic-related genes were identified by differential analysis and survival analysis. Univariate and multivariate Cox regression analyses were applied to determine an overall estimate of metabolic-related risk signature and related clinical parameters. The sensitivity and specificity of the risk signature were evaluated by time-dependent receiver operation characteristic (ROC) curves. TME immune cell infiltration mediated by metabolic-related genes was explored by gene set enrichment analysis (GSEA) and correlation analysis. Results: Seven metabolic-related genes (SMS, MTHFD2, HPRT1, DNMT1, PYGL, ADA, and P4HA1) were identified to develop a metabolic-related risk signature. The low-risk group had a better overall survival compared to that of the high-risk group in the TCGA and GSE65858 cohorts. The AUCs for 1-, 3-, and 5-year overall survival were 0.646 vs. 0.673, 0.694 vs. 0.639, and 0.673 vs. 0.573, respectively. The AUC vale of risk score was 0.727 vs. 0.673. The low-risk group was associated with immune cell infiltration in the TME. Conclusions: The metabolic-related risk signature were constructed and validated, which could involve in regulating the immune cell infiltration in the TME and act as an independent biomarker that predicted the prognosis of HNSCC.

学科与关键词

关键词
Head and neck squamous cell carcinomaMetabolicTumor microenvironmentPrognosisRisk signature
相关
加载中…
  • Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma
    Liu, Jun; Lu, Jianjun; Li, Wenli*BMC CANCER, 2022, 22(1): 352.被引 6
  • A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma
    Mai, Zizhao; Chen, Huan; Huang, Mingshu; Zhao, Xinyuan*; Cui, Li*Frontiers in Oncology, 2022, 11: 770241.被引 2
  • A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma
    Fang, Ruihua; Iqbal, Muhammad; Chen, Lin; Liao, Jing; Luo, Jierong; Wei, Fanqin; Wen, Weiping*; Sun, Wei*Aging-US, 2021, 13(8): 11507-11527.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Experimental Cell Research
发表日期
2023-07-15
卷期
第 428 卷, 第 2 期
页码
113628
DOI
10.1016/j.yexcr.2023.113628
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
Joint Research Fund for Enterprise and Basic and Applied Basic Research Programs of Guang- dong Province of China [2022A1515220011]

作者

  • C

    Cao, Yongxin (第一作者)

  • D

    Dai, Zili

    guangzhou med univ

查看全部 6 位作者收起作者
  • X

    Xie, Guofeng

    guangzhou med univ

  • L

    Liu, Guihong

  • G

    Guo, Liyi (通讯)

    6 · southern med univ

  • Z

    Zhang, Jian (通讯)

    guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417